Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) EBT Margin (2020 - 2025)

NeuroPace (NPCE) has 6 years of EBT Margin data on record, last reported at 10.26% in Q4 2025.

  • For Q4 2025, EBT Margin rose 1379.0% year-over-year to 10.26%; the TTM value through Dec 2025 reached 20.98%, up 1336.0%, while the annual FY2025 figure was 20.98%, 1336.0% up from the prior year.
  • EBT Margin reached 10.26% in Q4 2025 per NPCE's latest filing, up from 13.08% in the prior quarter.
  • Across five years, EBT Margin topped out at 10.26% in Q4 2025 and bottomed at 123.58% in Q2 2022.
  • Average EBT Margin over 5 years is 56.01%, with a median of 50.01% recorded in 2021.
  • Peak YoY movement for EBT Margin: tumbled -7308bps in 2022, then skyrocketed 6758bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 97.22% in 2021, then rose by 12bps to 86.01% in 2022, then skyrocketed by 58bps to 35.89% in 2023, then skyrocketed by 33bps to 24.06% in 2024, then skyrocketed by 57bps to 10.26% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 10.26% in Q4 2025, 13.08% in Q3 2025, and 34.72% in Q2 2025.